Elman Retina Group
Glen Burnie, Maryland, 21061, United States
NCT Number: NCT05281042
The study will enroll up to 30 AMD patients diagnosed with NV-AMD in at least one eye at the time of enrollment. At the Study Visit, fluid must be present in at least one eye of the subjects. If only one eye qualifies for enrollment, that will be assigned as the study eye. If both eyes are eligible, the study eye will be assigned according to a randomization schedule. Only one eye of each subject will be enrolled in the study. All subjects will be enrolled at 1 site in the United States. Subjects must meet all inclusion and no exclusion criteria.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Glen Burnie, Maryland, 21061, United States
Description of Study Procedures and In-Office Visit:
Enrollment/Screening:
At the Enrollment/ Screening Visit, the exams will be conducted in the following order:
i. Cataract ii. Glaucoma iii. Dry Eye iv. Other macula findings, e.g., epi retinal membrane, macular hole, vitreo-macular traction (VMT)
NOTE: Any planned treatment for NV-AMD should be administered after completion of all study-related scans
OCT Scans:
Scanning pattern to be used: Macular cube, 6X6mm, 128 B-scans per volume scan
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 5 minutes
volume [nl] of the TRF
Time frame: 5 minutes
volume [nl] of the IRF
Time frame: 5 minutes
volume [nl] of the SRF
Time frame: 5 minutes
volume [nl] of the TRF
Time frame: 5 minutes
volume [nl] of the IRF
Time frame: 5 minutes
volume [nl] of the SRF
Time frame: 5 minuts
Number of subjects and percentage of subjects who completed self-scanning on the Notal Home OCT, following a self-tutorial.
Notal Vision Inc.
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06190093
Age-Related Macular Degeneration, Eye Diseases
Arcadia, California, United States
View Trial DetailsNCT04516278
Age-Related Macular Degeneration, BRVO - Branch Retinal Vein Occlusion
Tucson, Arizona, United States
View Trial DetailsNCT05456828
Neovascular Age-related Macular Degeneration
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT05637255
Eye Diseases, Macular Degeneration
Brno, Czechia
View Trial Details